2019 annual financial data
Biodexa Pharmaceuticals 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -962.76%.
Operating income was -11,318,000 GBP and net income was -10,085,000 GBP.
Operating cash flow was -6,489,000 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 674,000 GBP
- Operating income
- -11,318,000 GBP
- Net income
- -10,085,000 GBP
- Operating cash flow
- -6,489,000 GBP